Stay updated on Quavonlimab Combo With Pembrolizumab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Quavonlimab Combo With Pembrolizumab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Quavonlimab Combo With Pembrolizumab in Advanced Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedA notice was added announcing NIH’s website transition and stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.3%

- Check8 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site as revision v3.7.2 instead of v3.7.1.SummaryDifference0.0%

- Check15 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check36 days agoChange DetectedAn updated revision entry (v3.7.0) was added to the study record history, while the previous revision (v3.6.6) was removed from the current history.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision: v3.6.6 was added to the history, replacing the previous Revision: v3.6.5. This update reflects the latest version in the study record history.SummaryDifference0.0%

- Check78 days agoChange DetectedThe footer revision tag has been updated from v3.6.4 to v3.6.5, replacing the previous version and signaling a new build of the page.SummaryDifference0.0%

Stay in the know with updates to Quavonlimab Combo With Pembrolizumab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Quavonlimab Combo With Pembrolizumab in Advanced Solid Tumors Clinical Trial page.